Ono Pharmaceutical Co., Ltd.

4528

JP3197600004

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.

Sector

Pharmaceuticals

Calendar

09/05/2024 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Ono Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,276 JPY

Average target price

2,714 JPY

Spread / Average Target

+19.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ONO PHARMACEUTICAL CO., LTD.	-8.37%	6.9B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.75B
OTSUKA HOLDINGS CO., LTD.	+26.49%	22.06B
SANDOZ GROUP AG	+15.11%	14.46B
CIPLA LIMITED	+12.33%	13.62B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.61B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.32B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.27%	4.8B

Generic Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:06:43 01/05/2024 am IST			5-day change	1st Jan Change
2,304 ^JPY	+1.23%		+0.65%	-8.37%

30/04	Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	RE
29/04	US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	MT

Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	30/04	RE
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	30/04	MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon	30/04	MT
Top Midday Gainers	30/04	MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	29/04	MT
Sector Update: Health Care	29/04	MT
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical	29/04	MT
Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma	29/04	DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	29/04	MT
Sector Update: Health Care	29/04	MT
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	29/04	MT
Deciphera Pharmaceuticals Gets $2.4 Billion Buyout Offer From ONO Pharmaceutical	29/04	DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	29/04	MT
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion	29/04	RE
Ono Pharmaceutical Co., Ltd. entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. for $2.2 billion.	29/04	CI
ONO Pharmaceuticals, Co., Ltd. Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL	21/03	CI
Sibylla Biotech Enters Strategic Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. in Central Nervous System Disorders	14/03	CI
Ono Pharmaceutical Co., Ltd. Enters into A University-Wide, Research Alliance Agreement with Harvard University	11/03	CI
Jefferies Adjusts Ono Pharmaceutical’s Price Target to 2,400 Yen From 2,300 Yen, Keeps at Hold	11/03	MT
Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.	04/03	CI
Ono Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 25, 2023, has closed with 18,732,400 shares, representing 3.88% for ¥49,999.75 million.	01/03	CI
Transcript : Ono Pharmaceutical Co., Ltd. - Special Call	22/02
InveniAI LLC Announces Collaboration with Ono Pharmaceutical for Target Discovery	19/02	CI
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	14/02	MT
Shattuck Strikes Joint Development Deal With Japan's Ono Pharma	13/02	DJ